about
The Quest for Anti-inflammatory and Anti-infective Biomaterials in Clinical TranslationOn/off-switchable anti-neoplastic nanoarchitectureMolecular Imprinting Applications in Forensic Science.Multistability in platelets and their response to gold nanoparticles.The potential legacy of cancer nanotechnology: cellular selection.Cell adhesion molecules and their relation to (cancer) cell stemness.MRI-visual order-disorder micellar nanostructures for smart cancer theranostics.Dual role of nanoparticles as drug carrier and drug.Multimodal electrophoresis of gold nanoparticles: a real time approach.Inflammation-sensitive in situ smart scaffolding for regenerative medicine.Inner-View of Nanomaterial Incited Protein Conformational Changes: Insights into Designable InteractionChanges in the allergenicity during different preparations of Pomfret, Hilsa, Bhetki and mackerel fish as illustrated by enzyme-linked immunosorbent assay and immunoblottingIn vivo interaction of gold nanoparticles after acute and chronic exposures in experimental animal modelsA MnO2 Nanoparticle-Dotted Hydrogel Promotes Spinal Cord Repair via Regulating Reactive Oxygen Species Microenvironment and Synergizing with Mesenchymal Stem CellsAdding Nanotechnology to the Metastasis Treatment ArsenalDissecting multi drug resistance in head and neck cancer cells using multicellular tumor spheroidsA repertoire of biomedical applications of noble metal nanoparticlesProbing ADP Induced Aggregation Kinetics During Platelet-Nanoparticle Interactions: Functional Dynamics Analysis to Rationalize Safety and BenefitsSingle-step formulation of levodopa-based nanotheranostics - strategy for ultra-sensitive high longitudinal relaxivity MRI guided switchable therapeutics
P50
Q28072029-EFD3FDAD-FAB3-4B08-9EF8-33B47FB0E8F2Q28389792-E0CEF77E-076B-433D-AD01-01DEA379D62CQ30356817-1CE2F3A4-6812-4297-AE44-2949D85403A9Q37839331-DF5EBCC2-75AC-4D0E-A93E-E14248D879A8Q38163663-AB85D65F-427A-4703-BC70-14B40E4D3AB7Q38188463-EAA90712-AD2F-4254-A054-E1905D5C8EB5Q39103975-C48DD6B6-41E5-4976-8A53-AF9E37BA4EBEQ39614059-5106A10E-BFD8-4089-8CB4-15CC51AA75B7Q39896151-C167D445-B3EB-49EA-B51D-153639B7C7D8Q51142935-35806483-4906-4676-9CFD-981D3BCF312AQ63512983-847158E4-901D-4E62-AEE1-835E441BE519Q79802052-5872D2E5-E369-4564-95F1-CC2822AE052CQ86933576-91072436-A4AB-4E43-9073-EAC06D2A857BQ91462722-70903BBD-4762-4322-91A7-7DF3BAF4FEC3Q91927188-53A12780-B2F7-43FB-96EF-20C49EC3252AQ92287458-07F8FA98-1FA1-4F56-AC21-5D8C3DC0E429Q92370689-4B4A72A2-5A21-470B-9C0A-2CFDB2CC8D1AQ92409333-0D8E6686-AD01-4CCB-B8A4-83F52151915CQ92846569-36DE19FC-F515-4A17-859E-674D60D05D1F
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Hirak K. Patra
@en
Patra HK
@nl
type
label
Hirak K. Patra
@en
Patra HK
@nl
altLabel
Patra HK
@en
prefLabel
Hirak K. Patra
@en
Patra HK
@nl
P108
P31
P496
0000-0002-6142-5489